References:
1. Picó MR, Lugo-Somolinos A, Sánchez JL, Burgos-Calderón R. Cutaneous alterations in patients with chronic renal failure. Int J Dermatol. déc 1992;31(12):860‑3.
2. Udayakumar P, Balasubramanian S, Ramalingam KS, Lakshmi C, Srinivas CR, Mathew AC. Cutaneous manifestations in patients with chronic renal failure on hemodialysis. Indian J Dermatol Venereol Leprol. 2006;72(2):119‑25.
3. Tajalli F, Mirahmadi SMS, Mozafarpoor S, Goodarzi A, Nasiri Partovi M, Lakestani D. Mucocutaneous manifestations of patients with chronic kidney disease under hemodialysis: A cross-sectional study of 49 patients. Dermatol Ther. juill 2021;34(4):e15015.
4. Hmida MB, Turki H, Hachicha J, Reygagne P, Rabier D, Zahaf A, et al. Hypopigmentation in hemodialysis. Acquired hair and skin fairness in a uremic patient undergoing maintenance hemodialysis: case report and review of the literature. Dermatol Basel Switz. 1996;192(2):148‑52.
5. Masmoudi A, Ben Hmida M, Mseddi M, Meziou TJ, Walha N, Hachicha J, et al. [Cutaneous manifestations of chronic hemodialysis. Prospective study of 363 cases]. Presse Medicale Paris Fr 1983. mars 2006;35(3 Pt 1):399‑406.
6. Gharibi L, Zouhair K, Ramdani B, Benchikhi H. Hair lightening in an hemodialysis patient treated by heptaminol (heptamyl). Dermatol Online J [Internet]. 1 avr 2009 [cité 8 févr 2024];15(4). Disponible sur: https://escholarship.org/uc/item/1cb7d4mw
7. Bublin JG, Thompson DF. Drug-induced hair colour changes. J Clin Pharm Ther. oct 1992;17(5):297‑302.
8. Di Giacomo TB, Valente NYS, Nico MMS. Chloroquine -induced hair depigmentation. Lupus. mars 2009;18(3):264‑6.
9. Routhouska S, Gilliam AC, Mirmirani P. Hair depigmentation during chemotherapy with a class III/V receptor tyrosine kinase inhibitor. Arch Dermatol. nov 2006;142(11):1477‑9.
10. Hendawy A. Hair Lightening of Three Hemodialysis Patients Under Heptaminol. Exp Tech Urol Nephrol. 19 mars 2019;2.